Assembly Biosciences, Inc.
ASMB
$9.08
$0.627.33%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.36M | 6.85M | 8.53M | 5.79M | 7.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.36M | 6.85M | 8.53M | 5.79M | 7.16M |
| Cost of Revenue | 14.28M | 13.52M | 16.26M | 11.88M | 11.01M |
| Gross Profit | -6.92M | -6.67M | -7.73M | -6.09M | -3.84M |
| SG&A Expenses | 4.61M | 4.29M | 4.48M | 4.64M | 8.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.89M | 17.80M | 20.74M | 16.51M | 19.71M |
| Operating Income | -11.53M | -10.96M | -12.20M | -10.73M | -12.55M |
| Income Before Tax | -10.41M | -9.61M | -10.75M | -9.08M | -10.93M |
| Income Tax Expenses | -76.00K | -- | 406.00K | -- | 33.00K |
| Earnings from Continuing Operations | -10.34M | -9.61M | -11.15M | -9.08M | -10.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.34M | -9.61M | -11.15M | -9.08M | -10.96M |
| EBIT | -11.53M | -10.96M | -12.20M | -10.73M | -12.55M |
| EBITDA | -11.50M | -10.92M | -12.17M | -10.70M | -12.47M |
| EPS Basic | -1.58 | -1.51 | -1.98 | -1.66 | -2.06 |
| Normalized Basic EPS | -1.00 | -0.95 | -1.19 | -1.03 | -1.28 |
| EPS Diluted | -1.58 | -1.51 | -1.98 | -1.66 | -2.06 |
| Normalized Diluted EPS | -1.00 | -0.95 | -1.19 | -1.03 | -1.28 |
| Average Basic Shares Outstanding | 6.54M | 6.35M | 5.64M | 5.48M | 5.32M |
| Average Diluted Shares Outstanding | 6.54M | 6.35M | 5.64M | 5.48M | 5.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
